Sanofi Moves Up In MS With Frexalimab Success

Anti-CD40L Antibody Significantly Reduced Disease Activity

 
• By Kevin Grogan
  
Sanofi
• Source: Sanofi
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category